BCRX - BioCryst Pharmaceuticals Inc Stock quote

TRADING
CENTER

8.97+0.07 / +0.79% Nov 24

BioCryst Pharmaceuticals Inc (NASDAQ GM:BCRX)

Quote Tools

Company Info

Portfolio

Prev. Close:

8.90

Open:

8.93

High:

9.18

Low:

8.71

Volume:

1,696,200

Volume Avg.:

2,814,400

52wk Range:

1.06 - 13.47

Market Cap (mil):

393.18

P/E Ratio:

0.00

Dividend Yield:

N/A

1d 5d 6m YTD 1y 3y 5y all data Advanced Charting

Create Alert at: $9 $9 $10 ...

Latest Headlines for BCRX

Nov 24	Cel-Sci's History of Disappearing Drugs: BioBuzz - at TheStreet.com
Nov 24	BioCryst Bull Blames Conspiracy for Stock's Fall: BioBuzz - at TheStreet.com
Nov 19	BioCryst Announces Pricing of Public Offering of Common Stock - PR Newswire
Nov 18	U.S. Sees Low Demand for BioCryst Flu Drug - at TheStreet.com
Nov 17	BioCryst Announces Proposed Public Offering of Common Stock - PR Newswire
Nov 5	Wall St set to rise on productivity boost - FT.com
Nov 5	BioCryst Receives First Peramivir Order From U.S. Government - PR Newswire
Nov 4	BioCryst's Partner Shionogi Files for Peramivir Regulatory Approval in Japan - PR Newswire
Oct 29	BioCryst to Present at Oppenheimer Healthcare Conference - PR Newswire
Oct 29	INTERVIEW-BioCryst happy to give away its first drug - Reuters
Oct 29	BioCryst Reports Third Quarter 2009 Financial Results and Provides Corporate Update - PR Newswire
Oct 26	Swine flu: Who's winning and losing in the H1N1 virus pandemic? - DailyFinance
Oct 26	Not 'too late' for H1N1 flu vaccine-US health secy - Reuters

More Headlines

CompetitorsFull list

		Last trade	Change/%change	P/E ratio
AMGN	Amgen Inc	56.80	0.55 / 0.98%	10.86
GILD	Gilead Sciences Inc	46.96	-0.05 / -0.11%	18.13
CELG	Celgene Corporation	55.37	-0.28 / -0.50%	66.71

Short InterestWhat is this? | Full list

Short Interest Date:

Oct 30 2009

Short Interest Shares:

10,346,766

Short Interest Ratio:

4.2

Float:

34,516,510

Short Interest as a % of Float:

41.3%

Average Daily Volume:

1,511,400

Outstanding Shares:

38,823,355

ProfileView full profile

BioCryst Pharmaceuticals, Inc. is a Delaware corporation, which was originally founded in 1986. It is a biotechnology company that designs, optimizes and develops novel drugs that block key enzymes involved in cancer, viral infections and autoimmune diseases. BioCryst integrates the necessary ... (more)

2008 Revenue:	$56.6 M	Headquarters: Birmingham, AL
Employees:	80	CEO: Jon P. Stonehouse
Net Income:	$-24,731,570.0	Industry: Biotechnology
Market Cap:	$370.8 M	Website: www.biocryst.com

Full Profile

Symbol	Price	Change/%Change	Prev. close	High	Low	Last Update	More Info
BCRX	8.97	+0.07 / +0.79%	8.90	9.18	8.71	Nov 24 12:00am ET	Profile Chart News

jobs by

Search for jobs

Search All Jobs from Across the Web

Home Portfolio Calculators Contact Us Newsletters Podcasts RSS Mobile Widgets Site Map User Preferences Advertise with Us
Magazine Customer Service Download Fortune Lists Reprints Career Opportunities Special Sections Conferences Business Leader Council

Live Quotes automatically refresh, but individual equities are delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.
* : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer

Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use.
MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data.
Fundamental data provided by Morningstar, Inc..
SEC Filings data provided by Edgar Online Inc..
Earnings data provided by FactSet CallStreet, LLC.